Mr. Vorhaus’s practice areas include life sciences and biotechnology, mergers and acquisitions, intellectual property and technology, venture capital and emerging growth companies and general corporate and commercial transactions. His experience includes representing both public and private companies in merger, acquisition and licensing transactions, private equity groups in complex acquisition, financing and licensing arrangements and investors, established and emerging companies, entrepreneurs and researchers in the development and commercialization of life sciences technologies.
As Editor of the Genomics Law Report, he is also actively engaged in the practice and development of the emerging field of law surrounding genomics and personalized medicine technologies.